Literature DB >> 3220090

Lack of impairment of fluocortolone disposition in oral contraceptive users.

U F Legler1.   

Abstract

Seven healthy women chronically (greater than 6 months) treated with oral contraceptives and 7 age- and weight-matched female controls were studied. Each subject was given 20 mg fluocortolone orally and the plasma concentrations of total and unbound fluocortolone in multiple samples obtained during the following 24 h were determined by HPLC and equilibrium dialysis. In the subjects on oral contraceptives there was no significant change in total clearance, unbound clearance or volume of distribution at steady-state of total and unbound fluocortolone, but there was a significant increase in hydrocortisone concentration compared to the control subjects. It appears that the elimination of the synthetic corticoid fluocortolone was not impaired by chronic administration of contraceptive steroids.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Methods--administraction and dosage; Developed Countries; Drugs--pharmacodynamics; Europe; Examinations And Diagnoses; Family Planning; Germany, Federal Republic Of; Laboratory Examinations And Diagnoses; Measurement; Metabolic Effects; Oral Contraceptives--administraction and dosage; Physiology; Research Methodology; Steroid Metabolic Effects--changes; Treatment; Western Europe

Mesh:

Substances:

Year:  1988        PMID: 3220090     DOI: 10.1007/bf00555517

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Pharmacokinetics of fluocortolone in man.

Authors:  U F Legler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.

Authors:  U F Legler; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  1986-04       Impact factor: 6.875

3.  The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.

Authors:  U Täuber; D Haack; B Nieuweboer; G Kloss; P Vecsei; H Wendt
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-01

4.  Increased metabolic clearance of acetaminophen with oral contraceptive use.

Authors:  D R Abernethy; M Divoll; H R Ochs; B Ameer; D J Greenblatt
Journal:  Obstet Gynecol       Date:  1982-09       Impact factor: 7.661

5.  Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

Authors:  P J Meffin; L M Wing; B C Sallustio; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 6.  The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.

Authors:  M L Orme
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

7.  [Metabolism of 6 -fluor-16 -methylpregna-1,4-dien-ll ,21-diol-3,20-dion (fluocortolone) in man. Isolation of 6 -hydroxylated metabolites (alkyl-substituted steroids VII)].

Authors:  E Gerhards; B Nieuweboer; G Schulz; H Gibian
Journal:  Acta Endocrinol (Copenh)       Date:  1971-09

8.  Fluocortolone: pharmacokinetics and effect on plasma cortisol level.

Authors:  U Täuber; K Richter; H Matthes
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.

Authors:  D R Abernethy; D J Greenblatt; H R Ochs; D Weyers; M Divoll; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1983-05       Impact factor: 6.875

10.  Prednisolone disposition and protein binding in oral contraceptive users.

Authors:  S J Boekenoogen; S J Szefler; W J Jusko
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

  10 in total
  1 in total

Review 1.  Clinical pharmacokinetics of contraceptive steroids. An update.

Authors:  G M Shenfield; J M Griffin
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.